glp 1 select trial Discover How GLP-1 Trials Are Not One-Size-Fit-All Long-term weight loss effects of

J Neural Transm (Vienna) 2018;125:12731286.ArticlePubMed 21

So I know you had asked the question earlier around the pandemic at Leisure Boom, and that was a category shift

Since the medication causes glucose-dependent insulin release and did not cause hypoglycemia but suppressed appetite, liraglutide and semaglutide were both approved for weight loss in patients without diabetes [33, 34]

, , :

Vieira IH, Barros LM, Baptista CF, Rodrigues DM, Paiva IM

And importantly, skeletal muscle does not appear to have a functional GLP-1 receptor, meaning these molecular effects are being mediated through indirect signaling pathways that we do not yet fully understand